Up to now, today's main capital had a net outflow of 7.92 billion dollars; there was a net inflow of 7.92 billion dollars in the pharmaceutical-biological, biomedical, and health China sectors, with a net inflow of 3,040 billion dollars in the pharmaceutical biotechnology sector; and the net outflow from the chip concept sector was 9.533 billion yuan. In terms of individual stocks, N Liqin ranked first with a net purchase of 650 million yuan, with net capital inflows from Tianfu Communications, Minovar, and JAC Motors; MegaYi Innovation ranked first with net sales of 758 million yuan, and the net outflows of Hengtong Optoelectronics, VeriSilicon, and Vanke A ranked first.

Up to now, today's main capital had a net outflow of 7.92 billion dollars; there was a net inflow of 7.92 billion dollars in the pharmaceutical-biological, biomedical, and health China sectors, with a net inflow of 3,040 billion dollars in the pharmaceutical biotechnology sector; and the net outflow from the chip concept sector was 9.533 billion yuan. In terms of individual stocks, N Liqin ranked first with a net purchase of 650 million yuan, with net capital inflows from Tianfu Communications, Minovar, and JAC Motors; MegaYi Innovation ranked first with net sales of 758 million yuan, and the net outflows of Hengtong Optoelectronics, VeriSilicon, and Vanke A ranked first.